Cardiac sarcoidosis (CS), an increasingly recognized disease of unknown etiology, is
associated with significant morbidity and mortality. Given the limited diagnostic yield of …

Cardiac sarcoidosis (CS) refers to the increasingly recognized cardiac involvement of an
incompletely understood systemic disease entity-sarcoidosis. Endomyocardial biopsy can …

Cardiac sarcoidosis (CS) is an increasingly recognized cause of heart failure and
arrhythmia. Historically challenging to identify, particularly in the absence of extracardiac …

Purpose of review The non-specific symptom profile and subclinical nature of disease along
with variable region of cardiac involvement in systemic sarcoidosis make the diagnosis …

Cardiac sarcoidosis is a granulomatous disease that may affect any organ, including the
heart. Diagnosis of cardiac sarcoidosis is challenging, given the varied and non-specific …

Cardiac sarcoidosis (CS) remains an intriguing infiltrating disorder and one of the most
important forms of inflammatory cardiomyopathy. Identification of patients with CS is of …

Sarcoidosis is a multisystem granulomatous disorder with a high prevalence of cardiac
involvement. Cardiac sarcoidosis (CS) may be life threatening due to end-stage …

Cardiac Sarcoidosis (CS) represents a unique diagnostic dilemma. Guidelines have been
recently revised to reflect the established role of sophisticated imaging techniques. Trans …

Cardiac sarcoidosis (CS) is a localized manifestation of multisystemic granulomatous
disorder of unknown etiology. It has heterogeneous manifestations depending on which …

Background: Sarcoidosis is a multisystem granulomatous disease with a neglected but high
prevalence of life-threatening cardiac involvement. Discussion: The clinical presentation of …